Insights into the molecular basis of c-di-GMP signalling in Pseudomonas aeruginosa .
Qishun FengJianuan ZhouLianhui ZhangYang FuLiang YangPublished in: Critical reviews in microbiology (2022)
The opportunistic human pathogen Pseudomonas aeruginosa can cause severe infections in immunocompromized people or cystic fibrosis (CF) patients. Because of its remarkable ability to invade the host and withstand the bacteriocidal effect of most conventional antibiotics, the infection caused by P. aeruginosa has become a major concern for human health. The switch from acute to chronic infection is governed by the second messenger bis-(3'-5')-cyclic dimeric guanosine mono-phosphate (c-di-GMP) in P. aeruginosa , and c-di-GMP is now recognized to regulate many important biological processes in pathogenesis. The c-di-GMP signalling mechanisms in P. aeruginosa have been studied extensively in the past decade, revealing complicated c-di-GMP metabolism and signalling network. In this review, the underlying mechanisms of this signalling network will be discussed, mainly focussing on how environmental cues regulate c-di-GMP signalling, protein-protein interaction mediated functional regulation, heterogeneity of c-di-GMP and cross talk between c-di-GMP signalling and other signalling systems. Understanding the molecular mechanism underlying the complex c-di-GMP signalling network would be beneficial for developing therapeutic approaches and antibacterial agents to combat the threat from P. aeruginosa .
Keyphrases
- biofilm formation
- pseudomonas aeruginosa
- cystic fibrosis
- candida albicans
- staphylococcus aureus
- escherichia coli
- human health
- acinetobacter baumannii
- risk assessment
- protein protein
- lung function
- end stage renal disease
- small molecule
- climate change
- chronic kidney disease
- drug induced
- chronic obstructive pulmonary disease
- intensive care unit
- extracorporeal membrane oxygenation
- early onset
- air pollution
- prognostic factors
- respiratory failure
- mechanical ventilation